MedPath

Automatic Administration of Oxygen During Respiratory Distress

Phase 1
Completed
Conditions
Acute Respiratory Distress Syndrome
Hypoxemia
Interventions
Device: Device FreeO2 v2.0
Registration Number
NCT02027181
Lead Sponsor
University Hospital, Brest
Brief Summary

Aim: The purpose of this study is to evaluate the use feasibility of FreeO2 so as to deliver automatically oxygen in the emergency department in a patient population admitted for acute respiratory failure.

Hypothesis: The principal hypothesis is that FreeO2 is possible and well-accepted by nurses and medical personnel and there are advantages to use this system. In comparison with the common oxygen delivery (the rotameter), the hypothesis is that FreeO2 system will make for a better control of the oxygen saturation in function of designed target, reducing the desaturation time and hyperoxia. We think that oxygen weaning will be faster than classical way if it is automated. In addition, FreeO2 could reduce the number of intervention by nurse personnel.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
190
Inclusion Criteria
  • Admission to the emergency for respiratory disease (or cardiac - acute pulmonary edema)justifying an oxygen administration to over 3 L / min to maintain a SpO2 ≥ 92%.
  • Inclusion within a time less than two hours after the start of the oxygen at the emergency.
  • Patient consent,or a close.
Exclusion Criteria
  • Necessity of an oxygen flow exceeds 15 L / min to maintain a SpO2 higher than 92%.
  • Criteria of gravity justifying immediately a different technique of ventilatory support:
  • Disturbance of consciousness with a Glasgow Coma Score ≤ 12
  • Serious ventricular rhythm disorders
  • Hemodynamic instability (SBP <80mmHg or recourse to vasopressors)
  • Cardiac or respiratory arrest
  • pH < 7.35 and PaCO2 > 55 mm Hg
  • Necessity of a urgent surgery, or coronary revascularization
  • Age <18 years
  • Pregnant women, lactating
  • Patient not relevant
  • Unavailability of the prototype FreeO2

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
device FreeO2Device FreeO2 v2.0Automatic adjustment of oxygen
Manual oxygenationDevice FreeO2 v2.0Manual adjustment of oxygen
Primary Outcome Measures
NameTimeMethod
Percentage of time spent in the target zone of oxygen saturation in the acute phase of treatment3 hours or 1 hour after after cessation of oxygenation

The target zone of oxygen saturation is : SpO2 = 92-96% The "acute phase of treatment" is defined by the 3 first hours of treatment by oxygenation and/or until one hour after the end of this last.

Secondary Outcome Measures
NameTimeMethod
Frequency of use of invasive or noninvasive ventilation during hospitalization.28 days max
nursing workload assessed by the number of manual Oxygen flow adjustments and airway management procedures3 days max
Maintaining EtCO2 in a selected area3 hours or 1 hour after after cessation of oxygenation
Oxygen consumption measured at the end of administration3 hours or 1 hour after after cessation of oxygenation
Time spent in a area of severe desaturation (SpO2 <88%) and a hyperoxia area (SpO2> 98%).3 hours or 1 hour after after cessation of oxygenation
Duration of administration during hospitalization28 days max
Number of complications related to the administration of oxygen28 days max

Trial Locations

Locations (4)

HIA Clermont Tonnerre

🇫🇷

Brest, France

Brest, University Hospital

🇫🇷

Brest, France

Institut universitaire de Cardiologie et de Pneumologie de Québec

🇨🇦

Quebec, Canada

Hopital Hotel Dieux de Levis

🇨🇦

Levis, Quebec, Canada

© Copyright 2025. All Rights Reserved by MedPath